U.S. pharmaceutical company ​Moderna is interested ‌in investing in production facilities in ​Germany, with ​an eye on ...

BioNTech’s CEO and his fellow co-founder will depart the biopharma by the end of the year to head up a new company focused on “next generation mRNA innovations.” Uğur Şahin, M.D., who is currently the ...

Just months after abruptly announcing the departure of its co-founders, BioNTech unveiled even more changes as the German drugmaker struggles to redefine itself in a post-pandemic market. BioNTech ...

Ugur Sahin and Özlem Türeci were instrumental in developing the first COVID-19 vaccine to be approved in the West. Now they ...